Litigation Details for Gilead Sciences, Inc. v. Apotex Inc. (D. Del. 2022)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Apotex Inc. (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-10-25 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 8,754,065; 9,296,769 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Apotex Inc.
Details for Gilead Sciences, Inc. v. Apotex Inc. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-10-26 | 1 | Complaint | U.S. Patent No. 8,754,065 (the “’065 patent”) and U.S. Patent No. 9,296,769 (the “’769 patent) (collectively…. This is an action for patent infringement arising under the patent laws of the United States, …collectively, the “TAF Patents-In-Suit”). Gilead is the owner of the TAF Patents-In-Suit. Gilead attaches… TAF PATENTS-IN-SUIT 25. On June 17, 2014, the U.S. Patent and Trademark Office…PageID #: 8 ’065 patent is attached hereto as Exhibit A. The claims of the ’065 patent are valid, enforceable | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |